Price T Rowe Associates Inc Avanos Medical, Inc. Transaction History

Price T Rowe Associates Inc

$836 Billion
Q2 2024

A detailed history of Price T Rowe Associates Inc transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 64,636 shares of AVNS stock, worth $1.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

64,636

Previous 60,898 6.14%

Holding current value

$1.35 Million

Previous $1.21 Million 6.18%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$17.85 - $20.42 $66,723 - $76,329	3,738 Added 6.14%	64,636 $1.29 Million
Q1 2024 May 15, 2024	SELL	$17.97 - $22.68 $3,450 - $4,354	-192 Reduced 0.31%	60,898 $1.21 Million
Q4 2023 Feb 14, 2024	BUY	$17.64 - $22.99 $45,528 - $59,337	2,581 Added 4.41%	61,090 $1.37 Million
Q3 2023 Nov 14, 2023	SELL	$19.93 - $26.31 $429,650 - $567,190	-21,558 Reduced 26.92%	58,509 $1.18 Million
Q2 2023 Aug 14, 2023	SELL	$22.53 - $30.98 $791,546 - $1.09 Million	-35,133 Reduced 30.5%	80,067 $2.05 Million
Q1 2023 May 15, 2023	SELL	$26.92 - $31.75 $301,530 - $355,631	-11,201 Reduced 8.86%	115,200 $3.43 Million
Q4 2022 Feb 14, 2023	SELL	$19.88 - $27.37 $13,041 - $17,954	-656 Reduced 0.52%	126,401 $3.42 Million
Q3 2022 Nov 14, 2022	SELL	$21.56 - $29.59 $208,204 - $285,750	-9,657 Reduced 7.06%	127,057 $2.77 Million
Q2 2022 Aug 15, 2022	BUY	$24.87 - $34.68 $4,327 - $6,034	174 Added 0.13%	136,714 $3.74 Million
Q1 2022 May 16, 2022	BUY	$28.87 - $35.77 $73,907 - $91,571	2,560 Added 1.91%	136,540 $4.57 Million
Q4 2021 Feb 14, 2022	SELL	$29.25 - $36.02 $59.3 Million - $73 Million	-2,027,116 Reduced 93.8%	133,980 $4.65 Million
Q3 2021 Nov 15, 2021	SELL	$31.2 - $38.5 $9.8 Million - $12.1 Million	-314,180 Reduced 12.69%	2,161,096 $67.4 Million
Q2 2021 Aug 16, 2021	SELL	$36.37 - $45.72 $27.1 Million - $34.1 Million	-745,607 Reduced 23.15%	2,475,276 $90 Million
Q1 2021 May 17, 2021	SELL	$43.5 - $53.4 $11.9 Million - $14.6 Million	-273,699 Reduced 7.83%	3,220,883 $141 Million
Q4 2020 Feb 16, 2021	BUY	$33.15 - $49.5 $116 Million - $173 Million	3,494,582 New	3,494,582 $160 Million

Others Institutions Holding AVNS

# of Institutions

272

Shares Held

41.9M

Call Options Held

800

Put Options Held

9.2K

View Full List

About AVANOS MEDICAL, INC.

Ticker AVNS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 46,487,000
Market Cap $974M
Description
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...

More about AVNS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Avanos Medical, Inc. Transaction History